Suppr超能文献

蛋白激酶C(Pkc)-δ介导精氨酸诱导的胰腺α细胞中胰高血糖素的分泌。

Protein Kinase C (Pkc)-δ Mediates Arginine-Induced Glucagon Secretion in Pancreatic α-Cells.

作者信息

Honzawa Norikiyo, Fujimoto Kei, Kobayashi Masaki, Kohno Daisuke, Kikuchi Osamu, Yokota-Hashimoto Hiromi, Wada Eri, Ikeuchi Yuichi, Tabei Yoko, Dorn Gerald W, Utsunomiya Kazunori, Nishimura Rimei, Kitamura Tadahiro

机构信息

Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo 105-8461, Japan.

Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15 Showa-machi, Maebashi 371-8512, Japan.

出版信息

Int J Mol Sci. 2022 Apr 4;23(7):4003. doi: 10.3390/ijms23074003.

Abstract

The pathophysiology of type 2 diabetes involves insulin and glucagon. Protein kinase C (Pkc)-δ, a serine-threonine kinase, is ubiquitously expressed and involved in regulating cell death and proliferation. However, the role of Pkcδ in regulating glucagon secretion in pancreatic α-cells remains unclear. Therefore, this study aimed to elucidate the physiological role of Pkcδ in glucagon secretion from pancreatic α-cells. Glucagon secretions were investigated in Pkcδ-knockdown InR1G9 cells and pancreatic α-cell-specific Pkcδ-knockout (αPkcδKO) mice. Knockdown of Pkcδ in the glucagon-secreting cell line InR1G9 cells reduced glucagon secretion. The basic amino acid arginine enhances glucagon secretion via voltage-dependent calcium channels (VDCC). Furthermore, we showed that arginine increased Pkcδ phosphorylation at Thr, which is critical for Pkcδ activation. Interestingly, the knockdown of Pkcδ in InR1G9 cells reduced arginine-induced glucagon secretion. Moreover, arginine-induced glucagon secretions were decreased in αPkcδKO mice and islets from αPkcδKO mice. Pkcδ is essential for arginine-induced glucagon secretion in pancreatic α-cells. Therefore, this study may contribute to the elucidation of the molecular mechanism of amino acid-induced glucagon secretion and the development of novel antidiabetic drugs targeting Pkcδ and glucagon.

摘要

2型糖尿病的病理生理学涉及胰岛素和胰高血糖素。蛋白激酶C(Pkc)-δ是一种丝氨酸-苏氨酸激酶,广泛表达并参与调节细胞死亡和增殖。然而,Pkcδ在胰腺α细胞中调节胰高血糖素分泌的作用仍不清楚。因此,本研究旨在阐明Pkcδ在胰腺α细胞胰高血糖素分泌中的生理作用。在Pkcδ敲低的InR1G9细胞和胰腺α细胞特异性Pkcδ敲除(αPkcδKO)小鼠中研究了胰高血糖素分泌。在分泌胰高血糖素的细胞系InR1G9细胞中敲低Pkcδ可减少胰高血糖素分泌。碱性氨基酸精氨酸通过电压依赖性钙通道(VDCC)增强胰高血糖素分泌。此外,我们发现精氨酸增加了Pkcδ在苏氨酸位点的磷酸化,这对Pkcδ的激活至关重要。有趣的是,在InR1G9细胞中敲低Pkcδ可减少精氨酸诱导的胰高血糖素分泌。此外,αPkcδKO小鼠和来自αPkcδKO小鼠的胰岛中精氨酸诱导的胰高血糖素分泌减少。Pkcδ对于胰腺α细胞中精氨酸诱导的胰高血糖素分泌至关重要。因此,本研究可能有助于阐明氨基酸诱导的胰高血糖素分泌的分子机制以及开发针对Pkcδ和胰高血糖素的新型抗糖尿病药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b9/8999522/059ce83b77c2/ijms-23-04003-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验